FDA Adverse Event Injury Summary report: N

CAPSUREFIX NOVUS

MDR report key: 4499184 · Received February 10, 2015

Report

Report Number
2649622-2015-01578
Event Type
Injury
Date Received
February 10, 2015
Date of Event
November 26, 2014
Report Date
November 26, 2014
Manufacturer
MPRI
Product Code
DTB
PMA / PMN Number
P930039
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
LA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE INFORMATION SUBMITTED REFLECTS ALL RELEVANT DATA RECEIVED. IF ADDITIONAL RELEVANT INFORMATION IS RECEIVED, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. CONCOMITANT: ADDR01 IPG IMPLANTED: 2011-(B)(6). (B)(4)

Additional Manufacturer Narrative · 1

PRODUCT EVENT SUMMARY: THE LEAD WAS NOT RETURNED FOR ANALYSIS. HOWEVER, PERFORMANCE DATA WAS RECEIVED AND ANALYZED. ANALYSIS OF THE DATA INDICATED THE IMPEDANCE ON THE ATRIAL PACING LEAD WAS BEYOND THE EXPECTED UPPER RANGE. AVERAGE WEEKLY ATRIAL LEAD IMPEDANCE RANGED FROM 821-1212 OHMS THROUGHOUT THE RECORD, WITH A MAXIMUM RECORDED IMPEDANCE OF 1248 OHMS.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT'S RIGHT ATRIAL (RA) LEAD SHOWED HIGH IMPEDANCE AND LOSS OF CAPTURE. SINUS EXIT BLOCK OR CONDUCTOR FRACTURE WERE SUSPECTED. THE RA LEAD WAS CAPPED AND REPLACED. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
95305 CAPSUREFIX NOVUS ELECTRODE, PACEMAKER, PERMANENT DTB MPRI 5076-52

Patients

Seq Age Sex Outcome Treatment
1 00079 YR Hospitalization| R 4092-58 LEAD